Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Psychoneuroimmunology: Diabetes and Cancer

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Current Landscape of Artificial Intelligence in Positron Emission Tomography (PET) Imaging Across the Cancer Continuum.

Journal of clinical medicine·2026

Same author

Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patients.

Bladder cancer (Amsterdam, Netherlands)·2026

Same author

Antibody-Drug Conjugates in urothelial, prostate, and renal cell cancers: A review of current and emerging therapies.

Critical reviews in oncology/hematology·2025

Same author

Unlocking precision: Bispecific T cell engagers and the next frontier in uro-oncology.

Critical reviews in oncology/hematology·2025

Same author

A call to action: improving access to cardiac MRI for diagnosis of immune checkpoint inhibitor related myocarditis in low and middle income countries.

Cardio-oncology (London, England)·2025

Same author

Perioperative Immunotherapy for Non-Small Cell Lung Cancer (NSCLC).

Current oncology reports·2025

Search research articles

Related Experiment Video

Updated: Jun 20, 2025

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

Refugees have cancer too.

Mona Ali Hassan¹, Akash Maniam¹

¹Portsmouth Hospital University NHS Trust, Portsmouth PO63LY, UK.

Ecancermedicalscience

|July 18, 2024

Summary

Providing cancer care in conflict zones and for refugees is a major global challenge. It requires international cooperation to ease the burden on patients and host nations.

Area of Science:

Oncology
Global Health
Public Health Policy

Background:

Cancer management is complex even in stable environments.
Conflict areas and refugee situations introduce significant political, economic, and health-related threats to cancer care.
Vulnerable populations, including refugees, face immense barriers to accessing timely and effective cancer treatment.

Discussion:

Effective cancer care in crisis settings necessitates robust international collaboration.
Coordination between international bodies, NGOs, and national governments is crucial.
Addressing the unique challenges of cancer patients in conflict zones requires tailored strategies.

Key Insights:

Cancer care provision in war zones and for refugee populations is a significant global health concern.

Keywords:

cancer care conflict areas refugees war

More Related Videos

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Related Experiment Videos

Last Updated: Jun 20, 2025

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Multifaceted threats complicate the delivery of oncology services in unstable regions.

Collaborative efforts are essential to mitigate the burden of cancer care.

Outlook:

Future strategies must prioritize sustainable cancer care models for displaced and conflict-affected populations.
Strengthening health systems in crisis-prone areas is vital for long-term cancer management.
Policy interventions should focus on equitable access to cancer treatment for all, regardless of geopolitical circumstances.